William O. Sandals

Array ( [id] => 4375217 [patent_doc_number] => 06303300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Poly (organo) phosphazenes for use in synthetic transfection systems' [patent_app_type] => 1 [patent_app_number] => 9/076899 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4878 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303300.pdf [firstpage_image] =>[orig_patent_app_number] => 076899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103369 [patent_doc_number] => 06056938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Cationic lipids and the use thereof' [patent_app_type] => 1 [patent_app_number] => 9/073181 [patent_app_country] => US [patent_app_date] => 1998-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21185 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 571 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/056/06056938.pdf [firstpage_image] =>[orig_patent_app_number] => 073181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991421 [patent_doc_number] => 05985573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Cationic polyacrylates and poly(alkyl) acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems' [patent_app_type] => 1 [patent_app_number] => 9/067276 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6233 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985573.pdf [firstpage_image] =>[orig_patent_app_number] => 067276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154016 [patent_doc_number] => 06156497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Recombinase-mediated generation of adenoviral vectors' [patent_app_type] => 1 [patent_app_number] => 9/051579 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 15421 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156497.pdf [firstpage_image] =>[orig_patent_app_number] => 051579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4348052 [patent_doc_number] => 06217870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor' [patent_app_type] => 1 [patent_app_number] => 9/057963 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 12880 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/217/06217870.pdf [firstpage_image] =>[orig_patent_app_number] => 057963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535773 [patent_doc_number] => 06337184 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Molecular marker for muscle stem cells' [patent_app_type] => B1 [patent_app_number] => 09/053031 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 9384 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337184.pdf [firstpage_image] =>[orig_patent_app_number] => 09053031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920921 [patent_doc_number] => 05914127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Isolation and uses of caveolae' [patent_app_type] => 1 [patent_app_number] => 9/024952 [patent_app_country] => US [patent_app_date] => 1998-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 12724 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914127.pdf [firstpage_image] =>[orig_patent_app_number] => 024952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345936 [patent_doc_number] => 06214547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Synthetic leader peptide sequences' [patent_app_type] => 1 [patent_app_number] => 9/012669 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7121 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214547.pdf [firstpage_image] =>[orig_patent_app_number] => 012669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986234 [patent_doc_number] => 05910415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Controlled modification of eukaryotic genomes' [patent_app_type] => 1 [patent_app_number] => 9/006232 [patent_app_country] => US [patent_app_date] => 1998-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 13941 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910415.pdf [firstpage_image] =>[orig_patent_app_number] => 006232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4405208 [patent_doc_number] => 06171861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Recombinational cloning using engineered recombination sites' [patent_app_type] => 1 [patent_app_number] => 9/005476 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 16351 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171861.pdf [firstpage_image] =>[orig_patent_app_number] => 005476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184607 [patent_doc_number] => 06093542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine RNA' [patent_app_type] => 1 [patent_app_number] => 9/005165 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5818 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093542.pdf [firstpage_image] =>[orig_patent_app_number] => 005165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406850 [patent_doc_number] => 06265159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Method for producing DNA nested deletions by an in vitro reaction using transposase' [patent_app_type] => 1 [patent_app_number] => 8/998712 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5049 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265159.pdf [firstpage_image] =>[orig_patent_app_number] => 998712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101811 [patent_doc_number] => 06051431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains' [patent_app_type] => 1 [patent_app_number] => 8/987067 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 61 [patent_no_of_words] => 24912 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051431.pdf [firstpage_image] =>[orig_patent_app_number] => 987067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1588292 [patent_doc_number] => 06482586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Hybrid compositions for intracellular targeting' [patent_app_type] => B1 [patent_app_number] => 08/975953 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 20286 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482586.pdf [firstpage_image] =>[orig_patent_app_number] => 08975953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049875 [patent_doc_number] => 05932422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase' [patent_app_type] => 1 [patent_app_number] => 8/970733 [patent_app_country] => US [patent_app_date] => 1997-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9901 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932422.pdf [firstpage_image] =>[orig_patent_app_number] => 970733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4056099 [patent_doc_number] => 05863765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Production in yeasts of stable antibody fragments' [patent_app_type] => 1 [patent_app_number] => 8/894922 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 5956 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863765.pdf [firstpage_image] =>[orig_patent_app_number] => 894922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352896 [patent_doc_number] => 06200751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Endothelial specific expression regulated by EPCR control elements' [patent_app_type] => 1 [patent_app_number] => 8/965729 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2951 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200751.pdf [firstpage_image] =>[orig_patent_app_number] => 965729 [rel_patent_id] =>[rel_patent_doc_number] =>)